September 6, 2018 04:24 AM | Covington Associates
Covington Associates LLC served as financial advisor to Scipher Medicine in its Series A financing. Scipher Medicine is the developer of a molecular technology platform that can predict if a patient will actually respond to a particular drug therapy. Further information can be viewed through the press release.
Covington Associates is an investment banking firm offering mergers and acquisitions (“M&A”) advisory to middle-market companies across the Healthcare, Business Services, Consumer & Industrial, and Technology verticals. Founded in 1991, the vision for Covington is to provide clients with the highest caliber of senior-level attention and to remain an advice driven and results focused organization. Since its inception, Covington Associates has completed more than 300 transactions globally for both private and publicly traded companies totaling over $15 billion. Further information can be found by visiting www.covllc.com.
Scipher Medicine is determined to ensure that patients are given access to drugs that work effectively — from day one. Its molecular technology platform predicts accurately whether a patient will respond to a particular therapy. For patients who don’t respond to existing drugs, the platform identifies new targets that can be used to develop more effective therapies. The company’s cofounders include Dr. Joseph Loscalzo, Hersey Professor of the Theory and Practice of Medicine at Harvard Medical School, Chairman of the Department of Medicine, and Physician-in-Chief at Brigham and Women’s Hospital and Dr. Albert-Laszlo Barabasi, Robert Gray Dodge Professor of Network Science and a Distinguished University Professor at Northeastern University. Scipher Medicine is a privately held company headquartered in Waltham, Massachusetts. To learn more, visit www.sciphermedicine.com.